Research from the University of Bath, funded by Cancer Research UK, published on No Smoking Day 2025, shows that integrating smoking cessation support into NHS Talking Therapies for depression and anxiety increases quit rates.
Intellia’s CRISPR-based treatment dramatically reduced patients’ swelling attacks in small trial
Intellia Therapeutics said Sunday that the first 10 patients to receive a CRISPR-based treatment for hereditary angioedema, a genetic disease, saw their swelling attacks —
June 2, 2024